You are here: Home » News-IANS » Health-Medicine
Business Standard

Researchers develop molecule, move step closer to treating common cold

IANS  |  London 

Moving closer to finding a cure for common cold, researchers have developed a molecule that may prevent the from attacking human cells.

Researchers from the in London have developed the molecule that targets protein called N-myristoyltransferase(NMT) which cold viruses need to build a protein 'shell', or capsid, which protects the genome.

According to the study, the new molecule attacks this protein instead of the which may, in turn, stop the formation of the resistant viruses.

The molecule also combats other related viruses that cause and

"is an inconvenience for most of us, but can cause serious complications in people with conditions like and A drug like this could be extremely beneficial, if given early in We are working on making a version that could be inhaled, so that it gets to the lungs quickly," said Ed Tate, at the at the

The results showed that the new molecule completely blocked several strains of the virus without affecting human cells. However, further study is needed to make sure that it is not toxic.

"The way the drug works means that we would need to be sure it was used against cold virus, and not similar conditions with different causes, to minimise the chance of toxic side effects," Tate added.

Presently, the remedies include treating symptoms instead of the virus as it is almost impossible to be get immunity against cold-causing viruses and hundred of variants which develop resistance quickly.

--IANS

sh/rt/tsb/vm

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 16 2018. 16:08 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU